Literature DB >> 22056526

Coating conditions matter to collagen matrix formation regarding von Willebrand factor and platelet binding.

Shlomit Mendelboum Raviv1, Katalin Szekeres-Csiki, Attila Jenei, Janos Nagy, Boris Shenkman, Naphtali Savion, Jolan Harsfalvi.   

Abstract

INTRODUCTION: Von Willebrand factor (VWF) and platelet binding needs a uniform collagen matrix therefore we aimed to find an optimal condition for the preparation of human type-I and type-III collagen matrices.
METHOD: The effects of pH, salt and ligand concentration and binding time were tested when collagen matrices were prepared by adsorption. Surface-bound collagen and collagen-bound VWF measured by specific antibodies. Platelet adhesion was tested under flow conditions at a shear rate of 1800s(-1) for 2 min. Matrices and platelets were visualized by atomic force and scanning electron microscope.
RESULTS: The extent of human collagens type-I and III binding to the surface was 10 and 4 times greater and binding was maximal under 8-16 hours, when coated from physiological buffer solution versus acid solution. Collagen fibrils were more developed and platelet adhesion was higher, with more organized and denser aggregates. VWF binding was parallel to the surface bound collagen in both collagen types.
CONCLUSION: Collagen coating of surfaces for VWF binding and platelet adhesion studies is very variable from acid solution. Our experiments provide evidences that neutralizing the acid and adding NaCl in physiological concentration, thereby facilitating formation of collagen fibril molecules in solution, results in efficient coating of human type-I and type III collagens, which then bind normal VWF equally well.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22056526     DOI: 10.1016/j.thromres.2011.09.030

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

1.  Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease.

Authors:  V H Flood; J C Gill; P A Christopherson; J S Wren; K D Friedman; S L Haberichter; R G Hoffmann; R R Montgomery
Journal:  J Thromb Haemost       Date:  2012-07       Impact factor: 5.824

2.  The Von Willebrand Factor A1-Collagen III Interaction Is Independent of Conformation and Type 2 Von Willebrand Disease Phenotype.

Authors:  Venkata R Machha; Alexander Tischer; Laurie Moon-Tasson; Matthew Auton
Journal:  J Mol Biol       Date:  2016-11-24       Impact factor: 5.469

3.  Collagen binding provides a sensitive screen for variant von Willebrand disease.

Authors:  Veronica H Flood; Joan Cox Gill; Kenneth D Friedman; Pamela A Christopherson; Paula M Jacobi; Raymond G Hoffmann; Robert R Montgomery; Sandra L Haberichter
Journal:  Clin Chem       Date:  2013-01-22       Impact factor: 8.327

4.  Major Changes of von Willebrand Factor Multimer Distribution in Cirrhotic Patients with Stable Disease or Acute Decompensation.

Authors:  Eszter Palyu; Jolan Harsfalvi; Tamas Tornai; Maria Papp; Miklos Udvardy; Katalin Szekeres-Csiki; Lajos Pataki; Karen Vanhoorelbeke; Hendrik B Feys; Hans Deckmyn; Istvan Tornai
Journal:  Thromb Haemost       Date:  2018-07-04       Impact factor: 5.249

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.